About Cellusion
Cellusion is a company based in Minato (Japan) founded in 2015.. Cellusion has raised $29.71 million across 2 funding rounds from investors including Nikon, Sparx Group and TOHO HOLDINGS. Cellusion operates in a competitive market with competitors including CorneaGen, EyeGate, Avedro, CorNeat Vision and EyeYon, among others.
- Headquarter Minato, Japan
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$29.71 M (USD)
in 2 rounds
-
Latest Funding Round
$20.22 M (USD), Series C
Jun 06, 2023
-
Investors
Nikon
& 12 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cellusion
Cellusion has successfully raised a total of $29.71M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $20.22 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series C — $20.2M
-
First Round
First Round
(06 Jan 2022)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Series C - Cellusion | Valuation | JIC Venture Growth Investments , Nissay Capital | |
| Jan, 2022 | Amount | Series B - Cellusion | Valuation | DBJ Capital , Keio Innovation Initiative |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cellusion
Cellusion has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Nikon, Sparx Group and TOHO HOLDINGS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on growth stage companies
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in biotech, adtech sectors
|
Founded Year | Domain | Location | |
|
Early-stage investments are targeted by Axil Capital, a VC firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cellusion
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cellusion
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cellusion Comparisons
Competitors of Cellusion
Cellusion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CorneaGen, EyeGate, Avedro, CorNeat Vision and EyeYon, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutic devices for corneal transplants are developed by CorneaGen.
|
|
| domain | founded_year | HQ Location |
Therapeutics and drug delivery systems for eye diseases are developed.
|
|
| domain | founded_year | HQ Location |
Corneal collagen cross-linking technology is developed for ophthalmic applications.
|
|
| domain | founded_year | HQ Location |
Nanotechnology-based artificial corneal implants are developed for ophthalmic use.
|
|
| domain | founded_year | HQ Location |
Ophthalmic devices for corneal edema treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cellusion
Frequently Asked Questions about Cellusion
When was Cellusion founded?
Cellusion was founded in 2015 and raised its 1st funding round 7 years after it was founded.
Where is Cellusion located?
Cellusion is headquartered in Minato, Japan. It is registered at Minato, Tokyo, Japan.
Who is the current CEO of Cellusion?
Shin Hatou is the current CEO of Cellusion.
Is Cellusion a funded company?
Cellusion is a funded company, having raised a total of $29.71M across 2 funding rounds to date. The company's 1st funding round was a Series B of $9.49M, raised on Jan 06, 2022.
What does Cellusion do?
Cellusion was founded in 2015 and is based in Minato City, Japan. Operations are centered in the biotechnology sector, with a focus on regenerative medicine. iPS cell-derived materials are developed for transplantation to replace damaged corneal endothelium. This approach is applied to treat bullous keratopathy through direct injection into the cornea, supporting clinical advancements in ocular therapies.
Who are the top competitors of Cellusion?
Who are Cellusion's investors?
Cellusion has 13 investors. Key investors include Nikon, Sparx Group, TOHO HOLDINGS, Keio Innovation Initiative, and Toyo Seikan Kaisha.